(Q52076407)

21 April 2018

title

Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases. (English)

1 reference

21 April 2018

author name string

Briani C

series ordinal

1

1 reference

21 April 2018

Santoro M

series ordinal

2

1 reference

21 April 2018

Latov N

series ordinal

3

1 reference

21 April 2018

publication date

1 August 2000

1 reference

21 April 2018

Journal of Neuroimmunology

published in

1 reference

21 April 2018

volume

108

1 reference

21 April 2018

page(s)

216-220

1 reference

21 April 2018

issue

1-2

1 reference

21 April 2018

Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Antibodies to chondroitin sulfate C: a new detection assay and correlations with neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Novel chondroitin sulfate-modified ligands for L-selectin on lymph node high endothelial venules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Insulin-dependent diabetes mellitus and glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Glycosaminoglycan antibodies in endocrine ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Heparan sulfate-like immunoreactivity in the spinal cord in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

A clinical, electrophysiological, morphological and immunological study of chronic sensory neuropathy with ataxia and paraesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Amorphous material of the skin in amyotrophic lateral sclerosis: a morphologic and biochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Hyaluronic acid is increased in the skin and urine in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Axonal neuropathy in a patient with monoclonal IgM kappa reactive with Schmidt-Lantermann incisures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Structure and biology of proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Monoclonal IgMK antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Isolation and characterization of glycosaminoglycans in brain of different species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Naturally-occurring antibodies which bind hyaluronate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Neuropathy in IgM lambda paraproteinemia. Immunoreactivity to neural proteins and chondroitin sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900260-5

7 January 2021

10.1016/S0165-5728(00)00260-5

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

10900356

1 reference

21 April 2018